Global Trends in Nicotine
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Transnational Tobacco Companies in Indonesia
The Indonesia Tobacco Market: Foreign Tobacco Company Growth Indonesia is the world’s third largest cigarette market by volume (excluding China) and there are approximately 57 million smokers in the country.2-3 According to one tobacco company, the Indonesia tobacco market consisting of hand-rolled kreteks, machine-rolled kreteks and white cigarettes was 270 billion sticks with a profit pool of RP 26.5 trillion ($2.95 billion USD) in 2010, an increase of 18% since 2007.1 Additionally, Indonesia’s cigarette retail volume and value are predicted to continue to grow consistently over the next five years.2 Indonesia’s growing cigarette market, large population, high smoking prevalence among men, and highly unregulated market, make the country an attractive business opportunity for international tobacco companies attempting to make up for falling profits in developed markets like the United States and Australia. The powerful presence and nature of transnational tobacco companies (TTCs) in Indonesia Source: BAT investor presentation1 increases the threat of the tobacco industry to public health because the companies’ competitive efforts to reach young consumers and female smokers ultimately increase smoking prevalence in markets where they operate. 4 Since 2005, the Indonesian market has shifted from being solely dominated by local manufacturers to a market where the number one, four and six spots are controlled by TTCs: Philip Morris International-owned Sampoerna, British American Tobacco-owned Bentoel, and KT&G-owned Trisakti respectively. In 2010, the combined market share of these three companies made up almost 40% of the Indonesian market.2 Leading local tobacco companies include Gudang Garam (number two), Djarum (number three) and Najorono Tobacco Indonesia (number five). -
I UNITED STATES DISTRICT COURT for the DISTRICT OF
Case 1:99-cv-02496-PLF Document 6276 Filed 08/03/18 Page 1 of 59 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA ____________________________________ UNITED STATES OF AMERICA, ) Plaintiff, ) Civil Action No. 99-CV-2496 (PLF) ) and ) ) CAMPAIGN FOR TOBACCO-FREE ) KIDS, et al., ) Plaintiff-Intervenors, ) ) v. ) ) PHILIP MORRIS USA INC., et al., ) Defendants. ) ) and ) ) ITG BRANDS, LLC, et al., ) Post-Judgment Parties ) Regarding Remedies ) PLAINTIFFS’ 2018 SUPPLEMENTAL BRIEF ON RETAIL POINT OF SALE REMEDY TABLE OF CONTENTS TABLE OF AUTHORITIES ......................................................................................................... iv INTRODUCTION .......................................................................................................................... 1 FACTUAL BACKGROUND ......................................................................................................... 5 I. The Deal between Cigarette Manufacturers and Retailers ............................................... 5 II. Benefits to Participating Retailers .................................................................................... 6 III. Manufacturers’ Contractual Control over Space for Cigarette Marketing and Promotional Displays ....................................................................................................... 8 A. The types of retail advertising and marketing space ........................................8 B. The manufacturers’ contractual authority over participating retailers’ space 10 1. The -
Access the Report
Contents Foreword 3 Executive Summary 4 Introduction 10 2020 Tobacco Transformation Index 15 Overall Ranking 16 Key Findings 17 Index Categories 26 1 Strategy and Management 27 2 Product Sales 34 3 Capital Allocation 41 4 Product Offer 48 5 Marketing 55 6 Lobbying & Advocacy 61 Company Profiles 64 Altria Group Inc. 65 British American Tobacco Plc 67 China National Tobacco Corp 69 Djarum PT 71 Eastern Co SAE 73 Gudang Garam Tbk PT 75 Imperial Brands Plc 77 ITC Ltd 79 Japan Tobacco Inc 81 KT&G Corp 83 Philip Morris International Inc 85 Swedish Match AB 87 Swisher International Group Inc 89 Tobacco Authority of Thailand 91 Vietnam National Tobacco Corp 93 Appendix 95 Index Scope 96 Indicators and Weights 101 Abbreviations 106 Definitions 107 Reference List 108 List of Sources 110 2020 Tobacco Transformation Index Foreword The Tobacco Transformation Index strives to stimulate competition among companies to deliver the necessary transformation of the tobacco industry for the benefit of public health. The Index creates value by highlighting differences across tobacco companies based on their actions in support of this transformation. Every two years, the Index will rank the world’s 15 most globally and regionally influential tobacco companies on their relative progress in supporting tobacco harm reduction. This ranking and supporting analyses will equip all stakeholders with valuable information for understanding and engaging with the companies to drive change. The Index is an initiative of the Foundation for a Smoke-Free World, compatible with the Industry Transformation pillar of its Strategic Plan and the smoke-free purposes set forth in its Certificate of Incorporation. -
Nicotine Replacement Therapy Using Medications to Help You Quit Smoking Can Double Your Chances of Quitting
Boston Medical Center Tobacco Treatment Team Tips to Get the Most Benefit From Your Nicotine Replacement Therapy Using medications to help you quit smoking can double your chances of quitting. To gain the most benefit, nicotine patches are often used in combination with nicotine gum or lozenges. Continue to use the patch and gum/lozenge for at least 6 weeks or as prescribed. You may keep a few pieces of gum or lozenge to use in order to prevent a relapse after the six weeks. If you have any questions concerning your nicotine replacement medications, contact your health care provider, pharmacist or call the Tobacco Treatment line at 617 638 7665. NICOTINE PATCHES How to use Every morning, place a fresh patch on a hairless area of skin between your neck and waist Keep the patch on for a full 24 hours before removing. When you remove the old patch, place a new patch on a different area of skin. o Using the same area of skin can cause skin irritation or rash, so it is best to rotate sites. The patch sticks best when skin is clean and dry. o Avoid lotion/oils on skin where you will place patch, as this may prevent the patch from sticking. o Do not use on skin that has a rash or cut. Helpful hints Some people notice trouble sleeping or nightmares after starting the patch. o If you have these, try taking the patch off each night at bedtime. o Place a new patch in the morning. It is best to avoid smoking while using the patch. -
PM 12.31.2014 Form 10K Wrap (Incl F/S & MD&A)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33708 PHILIP MORRIS INTERNATIONAL INC. (Exact name of registrant as specified in its charter) Virginia 13-3435103 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 120 Park Avenue, New York, New York 10017 (Address of principal executive offices) (Zip Code) 917-663-2000 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Common Stock, no par value New York Stock Exchange Floating Rate Notes due 2015 New York Stock Exchange 5.875% Notes due 2015 New York Stock Exchange 2.500% Notes due 2016 New York Stock Exchange 1.625% Notes due 2017 New York Stock Exchange 1.125% Notes due 2017 New York Stock Exchange 1.250% Notes due 2017 New York Stock Exchange 5.650% Notes due 2018 New York Stock Exchange 1.875% Notes due 2019 New York Stock Exchange 2.125% Notes due 2019 New York Stock Exchange 1.750% Notes due 2020 New York Stock Exchange 4.500% Notes due 2020 New York Stock Exchange 1.875% Notes due 2021 New York Stock Exchange 4.125% Notes due 2021 New York Stock Exchange 2.900% Notes due 2021 New York Stock Exchange -
Annual-Report-2020.Pdf
LAPORAN TAHUNAN LAPORAN TAHUNAN 2020 ANNUAL REPORT 2020 ANNUAL REPORT ANNUAL Kantor Pusat Headquarters Jl. Rungkut Industri Raya No.18 Surabaya 60293, Indonesia Telephone: +62-31-8431-699 Tbk. PT HM SAMPOERNA Facsimile: +62-31-8430-986 Kantor Perwakilan di Jakarta Corporate Representative Office in Jakarta One Pacific Place, 18th Floor Sudirman Central Business District (SCBD) Jl. Jend. Sudirman Kav.52-53 Jakarta 12190, Indonesia PT HM SAMPOERNA Tbk. Telephone: +62-21-5151-234 Facsimile: +62-21-5152-234 Website: www.sampoerna.com 2020 Email: [email protected] LAPORAN TAHUNAN | ANNUAL REPORT LAPORAN TAHUNAN LAPORAN TAHUNAN LAPORAN TAHUNAN 2020 ANNUAL REPORT 2020 ANNUAL REPORT ANNUAL Kantor Pusat Headquarters Jl. Rungkut Industri Raya No.18 Surabaya 60293, Indonesia Telephone: +62-31-8431-699 PT HM S Facsimile: +62-31-8430-986 Kantor Perwakilan di Jakarta Corporate Representative Office in Jakarta AMPOERNA One Pacific Place, 18th Floor Sudirman Central Business District (SCBD) Jl. Jend. Sudirman Kav.52-53 Jakarta 12190, Indonesia Telephone: +62-21-5151-234 Tbk. Facsimile: +62-21-5152-234 Website: www.sampoerna.com Email: [email protected] 2020 LAPORAN TAHUNAN | ANNUAL REPORT Daftar Isi Contents Ikhtisar Highlights Sekilas Sampoerna 4 Sampoerna at a Glance Fakta-fakta Penting 2020 6 2020 Key Facts Ikhtisar Utama 2020 8 Key Highlights 2020 Kinerja Utama dan Ikhtisar Keuangan 14 Key Performance and Financial Highlights Ikhtisar Saham 15 Stock Highlights Penghargaan dan Sertifikasi 16 Awards and Certifications -
Study Protocol – 24 March 2020
An Open-Label, Parallel Study to Assess Tobacco-Related Biomarkers of Exposure, Biomarkers of Potential Harm, and Nicotine Uptake During a 56-Day SwitcH to mybluTM e-Cigarettes in Adult Smokers NCT# 04019626 Study Protocol – 24 March 2020 An Open-Label, Parallel Study to Assess Tobacco-Related Biomarkers of Exposure, Biomarkers of Potential Harm, and Nicotine Uptake During a 56-Day Switch to my blu™ e-Cigarettes in Adult Smokers Sponsor Project No.: NER 01/001 Project No.: CA22747 Final Protocol: 28JAN2019 Protocol Amendment 1: 23APR2019 Protocol Amendment 2: 17MAY2019 Protocol Amendment 3: 24MAR2020 GCP Statement This study is to be performed in full compliance with the protocol, Good Clinical Practices (GCP), and applicable regulatory requirements. All required study documentation will be archived as required by regulatory authorities. Confidentiality Statement This document is confidential. It contains proprietary information of Nerudia Ltd. Any viewing or disclosure of such information that is not authorized in writing by Nerudia Ltd. is strictly prohibited. Such information may be used solely for the purpose of reviewing or performing this study. Page 1 CA22747_PROTOCOL AMENDMENT 3_24MAR2020 my blu Safety/Tolerability Study Project No.: CA22747 Nerudia Ltd. PRINCIPAL INVESTIGATOR SIGNATURE PAGE An Open-Label, Parallel Study to Assess Tobacco-Related Biomarkers of Exposure, Biomarkers of Potential Harm, and Nicotine Uptake During a 56-Day Switch to my ™ blu e-Cigarettes in Adult Smokers Principal Investigator: Printed Name: Site Name: Address: Tel.: Fax: E-mail: __________________________________ _________ Signature Date Page 7 CA22747_PROTOCOL AMENDMENT 3_24MAR2020 my blu Safety/Tolerability Study Project No.: CA22747 Nerudia Ltd. SYNOPSIS Study Objectives Primary: 1. -
Annex 2: Description of the Tobacco Market, Manufacturing of Cigarettes
EUROPEAN COMMISSION Brussels, 19.12.2012 SWD(2012) 452 final Part 3 COMMISSION STAFF WORKING DOCUMENT IMPACT ASSESSMENT Accompanying the document Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products (Text with EEA relevance) {COM(2012) 788 final} {SWD(2012) 453 final} EN EN A.2 DESCRIPTION OF THE TOBACCO MARKET, MANUFACTURING OF CIGARETTES AND THE MARKET OF RELATED NON-TOBACCO PRODUCTS A.2.1. The tobacco market.................................................................................................. 1 A.2.1.1. Tobacco products.............................................................................................. 1 A.2.1.2. Tobacco manufacturing .................................................................................... 6 A.2.1.3. Tobacco growing .............................................................................................. 8 A.2.1.4. Tobacco distribution levels............................................................................... 9 A.2.1.5. Upstream/downstream activities..................................................................... 10 A.2.1.6. Trade............................................................................................................... 10 A.2.2. Tobacco and Society............................................................................................... 11 A.2.2.1. -
Using the Nicotine Gum Using the Nicotine Gum Using the Nicotine Gum Using the Nicotine Gum
Using the Nicotine Gum Using the Nicotine Gum Using the Nicotine Gum Using the Nicotine Gum Nicorette® is a sugar-free nicotine gum used to help smokers slowly get off Nicorette® is a sugar-free nicotine gum used to help smokers slowly get off Nicorette® is a sugar-free nicotine gum used to help smokers slowly get off Nicorette® is a sugar-free nicotine gum used to help smokers slowly get off nicotine.When chewed correctly, and used on a regular schedule, it supplies a nicotine.When chewed correctly, and used on a regular schedule, it supplies a nicotine.When chewed correctly, and used on a regular schedule, it supplies a nicotine.When chewed correctly, and used on a regular schedule, it supplies a steady stream of nicotine to the body through the lining of the mouth.This steady stream of nicotine to the body through the lining of the mouth.This steady stream of nicotine to the body through the lining of the mouth.This steady stream of nicotine to the body through the lining of the mouth.This may help reduce the withdrawal symptoms that occur during the first weeks may help reduce the withdrawal symptoms that occur during the first weeks may help reduce the withdrawal symptoms that occur during the first weeks may help reduce the withdrawal symptoms that occur during the first weeks of quitting smoking. of quitting smoking. of quitting smoking. of quitting smoking. Obtaining the Gum: its taste.The nicotine gets into your bloodstream Obtaining the Gum: its taste.The nicotine gets into your bloodstream Obtaining the Gum: its taste.The nicotine -
Appendix 1: Codebook for “Content Analysis of E-Cigarette Products, Promotions, Prices and Claims on Internet Tobacco Vendor Websites, 2013-2014”
Appendix 1: Codebook for “Content Analysis of E-cigarette Products, Promotions, Prices and Claims on Internet Tobacco Vendor Websites, 2013-2014” (The following is a succinct version of the codebook intended to provide definitions for each variable; the original codebook used for training and reference by coders includes extensive text and graphic examples) Appendix Table 1. Codebook for Products sold by Internet Tobacco Vendors Selling E-Cigarettes Product (Variable) Codebook Definition Disposable e-cigarettes Any e-cigarette intended to be used and disposed of rather than refilled with e- liquids or cartridges. E-cigarette starter kit A kit containing everything needed to start vaping with a refillable e-cigarette, including the vaping device, battery, charger, and e-liquid or refill cartridges. Electronic cigars (e-cigars) An e-cigarette specifically made to resemble a large cigar, must use the term cigar, e.g. e-cigar or electronic cigar. Disposable e-cigars A disposable e-cigarette specifically made to resemble a large cigar (and be disposed of rather than refilled), must use the term cigar, e.g. e-cigar or electronic cigar. Most popular retail store Whether IEVs sold the five most popular e-cigarette brands in retail stores at the e-cigarette brands time of data collection (Blu, Njoy, Mistic, 21st Century Smoke, and Logic) were tracked in 2013. In 2014, Mistic and 21st Century Smoke were dropped because they were not found at all at IEVs in our 2013 sample, and four other brands found to be the most popular in our study of Google Search Trends were added to our brand tracking in 2014 (Joyetech, Ego, Nucig, and V2). -
Heated Cigarettes: How States Can Avoid Getting Burned
HEATED CIGARETTES: HOW STATES CAN AVOID GETTING BURNED 8/30/18 1 HEATED CIGARETTES HOW STATES CAN AVOID GETTING BURNED 8/30/18 2 THE PUBLIC HEALTH LAW CENTER 8/30/18 3 8/30/18 4 LEGAL TECHNICAL ASSISTANCE Legal Research Policy Development, Implementation, Defense Publications Trainings Direct Representation Lobby 8/30/18 5 HEATED CIGARETTES HOW STATES CAN AVOID GETTING BURNED • Presenters: – Kristy Marynak, MPP, Public Health Analyst, Centers for Disease Control and Prevention – Hudson Kingston, JD, LLM, Staff Attorney, Tobacco Control Legal Consortium at the Public Health Law Center 8/30/18 6 HEATED CIGARETTES HOW STATES CAN AVOID GETTING BURNED • Heated cigarettes on the global market • Distinguishing features 1. Heating at a temperature lower than conventional cigarettes that produce an inhalable aerosol • Heated Cigarettes: 450-700° F (generally) • Conventional cigarettes: 1250 – 1300 °F, • (max: 1500 °F) 2. Processed, commercial tobacco leaf is the nicotine source, flavor source, or both 8/30/18 7 HEATED CIGARETTES HOW STATES CAN AVOID GETTING BURNED Federal Regulation • Pre-Market Review • Modified Risk Tobacco Product Application • Vapeleaf 8/30/18 8 Heated Tobacco Products: Considerations for Public Health Policy and Practice KRISTY MARYNAK, MPP LEAD PUBLIC HEALTH ANALYST CDC OFFICE ON SMOKING AND HEALTH TOBACCO CONTROL LEGAL CONSORTIUM WEBINAR AUGUST 2018 8/30/18 9 What’s the public health importance of this topic? The landscape of tobacco products is continually changing By being proactive and anticipating new products, we can -
Transforming Our Business
Transforming our business A cigarette manufacturing line (on the left-hand side) and a heated tobacco unit manufacturing line (on the right-hand side) at our factory in Neuchâtel, Switzerland Replacing cigarettes with While several attempts have been made to develop better alternatives to smoking, smoke-free products drawbacks in the technological capability of these products and a lack of consumer In 2017, PMI manufactured and shipped acceptance rendered them unsuccessful. 791 billion cigarettes and other Recent advances in science and combustible tobacco products and technology have made it possible to 36 billion smoke‑free products, reaching develop innovative products that approximately 150 million adult consumers consumers accept and that are less in more than 180 countries. harmful alternatives to continued smoking. Smoking cigarettes causes serious PMI has developed a portfolio of disease. Smokers are far more likely smoke‑free products, including heated Contribution of Smoke-Free than non‑smokers to get heart disease, tobacco products and nicotine‑containing Products to PMI’s Total lung cancer, emphysema, and other e‑vapor products that have the potential diseases. Smoking is addictive, and it Net Revenues to significantly reduce individual risk and 13% can be very difficult to stop. population harm compared to cigarettes. The best way to avoid the harms of Many stakeholders have asked us about smoking is never to start, or to quit. the role of these innovative smoke‑free But much more can be done to improve products in the context of our business the health and quality of life of those vision. Are these products an extension of who continue to use nicotine products, our cigarette product portfolio? Are they through science and innovation.